187 results
8-K
HROW
Harrow Inc
8 Sep 14
Departure of Directors or Certain Officers
12:00am
of the Nominations and Corporate Governance Committee.
Mr. Nelson served as the President and the Chief Executive Officer of Intermountain Healthcare … , an integrated nonprofit healthcare system with hospitals, surgery centers, clinics and an insurance organization, from 1999 until his retirement in early 2009
8-K
HROW
Harrow Inc
30 Sep 20
Departure of Directors or Certain Officers
4:46pm
on healthcare management and economics. A nontraditional academic, his activity spans business, health policy, and academia. His research has appeared … . Since its founding, he has been Governance Committee Chair and Compensation Committee Member for Community Healthcare Trust Incorporated (NYSE: CHCT
8-K
EX-99.1
HROW
Harrow Inc
31 Dec 18
Harrow Health, Inc. Name Reflects the Company’s Commitment to the Future of Healthcare
7:00am
to the Future of Healthcare
San Diego, Calif. – December 31, 2018 – Harrow Health, Inc. (formerly known as Imprimis Pharmaceuticals, Inc.) (NASDAQ … a diversified portfolio of healthcare businesses that meet the needs of healthcare providers and patients across America. The future of healthcare involves
8-K
HROW
Harrow Inc
31 Mar 22
Departure of Directors or Certain Officers
8:30am
ophthalmic pharmaceuticals.
Marty Makary, M.D., M.P.H., age 51, is a healthcare expert and is Chief of Islet Transplant Surgery at The Johns Hopkins … for The Wall Street Journal. He is the author of two New York Times bestselling books on healthcare and has published over 250 scientific peer-reviewed
8-K
EX-99.2
HROW
Harrow Inc
13 May 24
Harrow Announces First Quarter 2024 Financial Results
4:25pm
third of 2024.
Before I jump into the above subjects, I want to touch on (a) the Change Healthcare (Change) cyberattack and 2024 Guidance and (b) Greg … DiPasquale joining Harrow as Senior Vice President, Head of Commercial.
Change Healthcare Cyberattack and 2024 Guidance
Rest assured that our team
8-K
EX-99.1
xa22xlrem2k427rto6o4
10 Aug 20
Harrow Health Publishes Second Quarter 2020 Letter to Stockholders
4:05pm
8-K
EX-99.1
trucluc
29 May 19
Harrow Health Announces Renegotiated Debt Facility with SWK Holdings
7:30am
8-K
EX-99.1
smi2c
8 Mar 21
Harrow Health Announces Fourth Quarter and Year-End 2020 Financial Results
4:15pm
8-K
EX-99.1
b4az xk1s
27 Jul 21
Harrow Health Acquires Patented Ophthalmic Surgical Drug Candidate from Sintetica
7:30am
8-K
EX-99.1
0ewqn5phi8mdvfd
9 Nov 20
Harrow Health Publishes Third Quarter 2020 Letter to Stockholders
4:25pm
8-K
EX-99.1
d6vp5q7un2not3in m6x
11 May 20
Harrow Health Publishes First Quarter 2020Letter to Stockholders
4:20pm
8-K
EX-99.1
j5urrvqxwgyqizx2g
13 Nov 19
Harrow Health Publishes Third QuarterLetter to Stockholders
4:05pm
8-K
EX-99.1
ztcmx
17 Nov 20
Harrow Health Publishes Third Quarter 2020 Letter to Stockholders
7:30am
8-K
EX-99.1
xx2c9sfkhceu wg
9 Nov 21
Harrow Health Announces Third Quarter 2021 Financial Results
4:05pm
8-K
a86ncsmr3a3
20 Dec 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
jm0i z8imtd
18 Aug 21
Harrow Health Acquires Ophthalmic Surgical Drug Candidate
7:30am
8-K
4ocp r1z3
27 Jun 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
dmjcxs5d
13 Mar 20
Harrow Health Publishes Fourth Quarter 2019Letter to Stockholders
8:10am
8-K
EX-99.1
8c3 a0xgdju4o3odz5
10 Aug 21
Harrow Health Announces Second Quarter 2021 Financial Results
4:15pm
8-K
EX-99.1
uknyqrbklke
20 Dec 21
Harrow Health Acquires U.S. Commercial Rights to Four Branded Eye Drops
8:05am